Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 16Active not recruiting 12Recruiting 9Terminated 2Suspended 1Not yet recruiting 1Available 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1

Interventions

Specimen Handling 81Bevacizumab 66Drug Therapy 64Cisplatin 62Magnetic Resonance Spectroscopy 61Carboplatin 60Gemcitabine 56Radiotherapy 55Cyclophosphamide 55pembrolizumab 52Oxaliplatin 50Capecitabine 50toripalimab 42Paclitaxel 41tislelizumab 40Standard of Care 40Biopsy 38fludarabine 36Fluorouracil 35venetoclax 32Blood Specimen Collection 31Injections 30Immune Checkpoint Inhibitors 30anlotinib 29Nivolumab 29Irinotecan 29Docetaxel 29Surgical Procedures, Operative 28Leucovorin 26Dexamethasone 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Peripheral Blood Stem Cell Transplantation × 1 year × Clear all
NCT07582172 2026-05-12

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

City of Hope Medical Center

Phase 2 Not yet recruiting
35 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡